CELLADON CORPORATION, A DELAWARE CORPORATION

Organization

SAN DIEGO, CA, US

Ticker Symbols

NASDAQ:EIGR

BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Address
2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Mailing Address
2155 PARK BOULEVARD PALO ALTO CA 94306
State Location
CA
State of Incorporation

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Pharmaceutical compositions comprising lonafarnib and ritonavir
- Patent number 12,029,819
- Issue date Jul 9, 2024
- Eiger BioPharmaceuticals, Inc.
- Patrick Gosselin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of hepatitis delta virus infection
- Patent number 11,793,793
- Issue date Oct 24, 2023
- Eiger BioPharmaceuticals, Inc.
- David A. Cory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of using buffered formulations of exendin (9-39)
- Patent number 11,738,086
- Issue date Aug 29, 2023
- Eiger BioPharmaceuticals, Inc.
- Xiaofeng Xiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the treatment of non-alcoholic steatohepatitis
- Patent number 11,571,403
- Issue date Feb 7, 2023
- Eiger BioPharmaceuticals, Inc.
- Xiaofeng Xiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating hepatitis delta virus infection
- Patent number 11,517,532
- Issue date Dec 6, 2022
- Eiger BioPharmaceuticals, Inc.
- Patrick Gosselin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of hepatitis delta virus infection
- Patent number 11,311,519
- Issue date Apr 26, 2022
- Eiger BioPharmaceuticals, Inc.
- David A. Cory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives
- Patent number 11,116,820
- Issue date Sep 14, 2021
- Eiger BioPharmaceuticals, Inc.
- Xiaofeng Xiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Buffered formulations of exendin (9-39)
- Patent number 11,020,484
- Issue date Jun 1, 2021
- Eiger BioPharmaceuticals, Inc.
- Xiaofeng Xiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of hepatitis delta virus infection with interferon lambda
- Patent number 10,953,072
- Issue date Mar 23, 2021
- Eiger BioPharmaceuticals, Inc.
- Eduardo Bruno Martins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of hepatitis delta virus infection
- Patent number 10,828,283
- Issue date Nov 10, 2020
- Eiger BioPharmaceuticals, Inc.
- David A. Cory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives
- Patent number 10,653,753
- Issue date May 19, 2020
- Eiger BioPharmaceuticals, Inc.
- Xiaofeng Xiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and pharmaceutical compositions for the treatment of non-al...
- Patent number 10,588,880
- Issue date Mar 17, 2020
- Eiger BioPharmaceuticals, Inc.
- Xiaofeng Xiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of hepatitis delta virus infection
- Patent number 10,076,512
- Issue date Sep 18, 2018
- Eiger BioPharmaceuticals, Inc.
- David A. Cory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for enhanced uptake of viral vectors in the myocardium
- Patent number 8,636,998
- Issue date Jan 28, 2014
- Celladon Corporation
- Krisztina Maria Zsebo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fluorescence resonance energy transfer assays for sarco/endoplasmic...
- Patent number 8,431,356
- Issue date Apr 30, 2013
- Regents of the University of Minnesota
- David D. Thomas
- G01 - MEASURING TESTING
Information Patent Grant
Method for enhanced uptake of viral vectors in the myocardium
- Patent number 8,221,738
- Issue date Jul 17, 2012
- Celladon Corporation
- Krisztina Maria Zsebo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS OF EXENDIN-4 DERIVATIVES
- Publication number 20240316156
- Publication date Sep 26, 2024
- Eiger BioPharmaceuticals, Inc.
- Xiaofeng Xiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CONGENITAL HYPERINSULINISM WITH AVEXITIDE
- Publication number 20240307501
- Publication date Sep 19, 2024
- Eiger BioPharmaceuticals, Inc.
- Colleen M. Craig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF HEPATITIS DELTA VIRUS INFECTION
- Publication number 20240277676
- Publication date Aug 22, 2024
- Eiger BioPharmaceuticals, Inc.
- David A. Cory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATING LAMINOPATHIES
- Publication number 20240207243
- Publication date Jun 27, 2024
- Eiger BioPharmaceuticals, Inc.
- Richard Anthony FRANCO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF HEPATITIS E VIRUS INFECTION WITH INTERFERON LAMBDA
- Publication number 20240108691
- Publication date Apr 4, 2024
- Eiger BioPharmaceuticals, Inc.
- Andre Boonstra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS TO TREAT HEPATITIS DELTA VIRAL INFECTIONS
- Publication number 20240082360
- Publication date Mar 14, 2024
- Eiger BioPharmaceuticals, Inc.
- Ingrid CHOONG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Buffered Formulations Of Exendin (9-39)
- Publication number 20240042035
- Publication date Feb 8, 2024
- Eiger BioPharmaceuticals, Inc.
- Xiaofeng Xiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CORONAVIRUS INFECTION WITH INTERFERON LAMBDA
- Publication number 20230285510
- Publication date Sep 14, 2023
- Eiger BioPharmaceuticals, Inc.
- Jeffrey GLENN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING LONAFARNIB AND RITONAVIR
- Publication number 20230218530
- Publication date Jul 13, 2023
- Eiger BioPharmaceuticals, Inc.
- PATRICK GOSSELIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CORONAVIRUS INFECTION WITH INTERFERON LAMBDA
- Publication number 20230201308
- Publication date Jun 29, 2023
- Eiger BioPharmaceuticals, Inc.
- Jeffrey GLENN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF HEPATITIS DELTA VIRUS INFECTION
- Publication number 20230046607
- Publication date Feb 16, 2023
- Eiger BioPharmaceuticals, Inc.
- David A. Cory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF HEPATITIS DELTA VIRUS INFECTION
- Publication number 20220023287
- Publication date Jan 27, 2022
- Eiger BioPharmaceuticals, Inc.
- David Cory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS OF EXENDIN-4 DERIVATIVES
- Publication number 20210369814
- Publication date Dec 2, 2021
- Eiger BioPharmaceuticals, Inc.
- Xiaofeng Xiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NON-AL...
- Publication number 20210369693
- Publication date Dec 2, 2021
- Eiger BioPharmaceuticals, Inc.
- David CORY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AVEXITIDE FOR THE TREATMENT OF HYPERINSULINEMIC HYPOGLYCEMIA
- Publication number 20210338780
- Publication date Nov 4, 2021
- Eiger BioPharmaceuticals, Inc.
- Colleen M. CRAIG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Buffered Formulations Of Exendin (9-39)
- Publication number 20210315995
- Publication date Oct 14, 2021
- Eiger BioPharmaceuticals, Inc.
- Xiaofeng Xiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATING LAMINOPATHIES
- Publication number 20210267961
- Publication date Sep 2, 2021
- Eiger BioPharmaceuticals, Inc.
- Richard Anthony Franco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA
- Publication number 20210228686
- Publication date Jul 29, 2021
- Eiger BioPharmaceuticals, Inc.
- Eduardo Bruno Martins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATING LAMINOPATHIES
- Publication number 20210121454
- Publication date Apr 29, 2021
- Eiger BioPharmaceuticals, Inc.
- Richard Anthony Franco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING LONAFARNIB AND RITONAVIR
- Publication number 20210093571
- Publication date Apr 1, 2021
- Eiger BioPharmaceuticals, Inc.
- PATRICK GOSSELIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF HEPATITIS DELTA VIRUS INFECTION
- Publication number 20200375955
- Publication date Dec 3, 2020
- Eiger BioPharmaceuticals, Inc.
- David A. Cory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF HYPERINSULINEMIC HYPOGLYCEMIA WITH EXENDIN-4 DERIVATIVES
- Publication number 20200297819
- Publication date Sep 24, 2020
- Eiger BioPharmaceuticals, Inc.
- Xiaofeng Xiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NON-AL...
- Publication number 20200237696
- Publication date Jul 30, 2020
- Eiger BioPharmaceuticals, Inc.
- Xiaofeng Xiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Buffered Formulations Of Exendin (9-39)
- Publication number 20200069802
- Publication date Mar 5, 2020
- Eiger BioPharmaceuticals, Inc.
- Xiaofeng Xiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NON-AL...
- Publication number 20190307714
- Publication date Oct 10, 2019
- Eiger BioPharmaceuticals, Inc.
- Xiaofeng Xiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF HEPATITIS DELTA VIRUS INFECTION
- Publication number 20190167646
- Publication date Jun 6, 2019
- Eiger BioPharmaceuticals, Inc.
- David A. Cory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA
- Publication number 20190111110
- Publication date Apr 18, 2019
- Eiger BioPharmaceuticals, Inc.
- Eduardo Bruno Martins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment Of Hyperinsulinemic Hypoglycemia With Exendin-4 Derivatives
- Publication number 20190060413
- Publication date Feb 28, 2019
- Eiger BioPharmaceuticals, Inc.
- Xiaofeng Xiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF HEPATITIS DELTA VIRUS INFECTION
- Publication number 20180338993
- Publication date Nov 29, 2018
- Eiger BioPharmaceuticals, Inc.
- David Cory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING LONAFARNIB AND RITONAVIR
- Publication number 20180110734
- Publication date Apr 26, 2018
- Eiger BioPharmaceuticals, Inc.
- Patrick Gosselin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
90112290 - EIGER ONE CARE
- Serial number 90112290
- Filing date Aug 13, 2020
- Eiger BioPharmaceuticals, Inc.
- 35 - Advertising
Information Trademark
90087462 - EIGERONECARE
- Serial number 90087462
- Registration number 6336945
- Filing date Aug 1, 2020
- Eiger BioPharmaceuticals, Inc.
- 35 - Advertising
Information Trademark
90087464 - EIGER ONECARE
- Serial number 90087464
- Registration number 6336946
- Filing date Aug 1, 2020
- Eiger BioPharmaceuticals, Inc.
- 35 - Advertising
Information Trademark
90005739 - ZOKINVY
- Serial number 90005739
- Registration number 6317378
- Filing date Jun 17, 2020
- Eiger BioPharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88892713 - EIGERCARE
- Serial number 88892713
- Filing date Apr 29, 2020
- Eiger BioPharmaceuticals, Inc.
- 35 - Advertising
Information Trademark
78979488 - MYDICAR
- Serial number 78979488
- Registration number 3370955
- Filing date Oct 6, 2005
- Celladon Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78728282 - MYDICAR
- Serial number 78728282
- Filing date Oct 6, 2005
- Celladon Corporation
- 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth

CELLADON CORPORATION, A DELAWARE CORPORATION

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Pharmaceutical compositions comprising lonafarnib and ritonavir

Treatment of hepatitis delta virus infection

Methods of using buffered formulations of exendin (9-39)

Methods for the treatment of non-alcoholic steatohepatitis

Methods of treating hepatitis delta virus infection

Treatment of hepatitis delta virus infection

Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives

Buffered formulations of exendin (9-39)

Treatment of hepatitis delta virus infection with interferon lambda

Treatment of hepatitis delta virus infection

Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives

Methods and pharmaceutical compositions for the treatment of non-al...

Treatment of hepatitis delta virus infection

Method for enhanced uptake of viral vectors in the myocardium

Fluorescence resonance energy transfer assays for sarco/endoplasmic...

Method for enhanced uptake of viral vectors in the myocardium

Patents Applicationslast 30 patents

COMPOSITIONS OF EXENDIN-4 DERIVATIVES

TREATMENT OF CONGENITAL HYPERINSULINISM WITH AVEXITIDE

TREATMENT OF HEPATITIS DELTA VIRUS INFECTION

METHOD OF TREATING LAMINOPATHIES

TREATMENT OF HEPATITIS E VIRUS INFECTION WITH INTERFERON LAMBDA

METHODS TO TREAT HEPATITIS DELTA VIRAL INFECTIONS

Buffered Formulations Of Exendin (9-39)

TREATMENT OF CORONAVIRUS INFECTION WITH INTERFERON LAMBDA

PHARMACEUTICAL COMPOSITIONS COMPRISING LONAFARNIB AND RITONAVIR

TREATMENT OF CORONAVIRUS INFECTION WITH INTERFERON LAMBDA

TREATMENT OF HEPATITIS DELTA VIRUS INFECTION

TREATMENT OF HEPATITIS DELTA VIRUS INFECTION

COMPOSITIONS OF EXENDIN-4 DERIVATIVES

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NON-AL...

AVEXITIDE FOR THE TREATMENT OF HYPERINSULINEMIC HYPOGLYCEMIA

Buffered Formulations Of Exendin (9-39)

METHOD OF TREATING LAMINOPATHIES

TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA

METHOD OF TREATING LAMINOPATHIES

PHARMACEUTICAL COMPOSITIONS COMPRISING LONAFARNIB AND RITONAVIR

TREATMENT OF HEPATITIS DELTA VIRUS INFECTION

TREATMENT OF HYPERINSULINEMIC HYPOGLYCEMIA WITH EXENDIN-4 DERIVATIVES

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NON-AL...

Buffered Formulations Of Exendin (9-39)

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NON-AL...

TREATMENT OF HEPATITIS DELTA VIRUS INFECTION

TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA

Treatment Of Hyperinsulinemic Hypoglycemia With Exendin-4 Derivatives

TREATMENT OF HEPATITIS DELTA VIRUS INFECTION

PHARMACEUTICAL COMPOSITIONS COMPRISING LONAFARNIB AND RITONAVIR

Trademarklast 30 trademarks

90112290 - EIGER ONE CARE

90087462 - EIGERONECARE

90087464 - EIGER ONECARE

90005739 - ZOKINVY

88892713 - EIGERCARE

78979488 - MYDICAR

78728282 - MYDICAR